Soleno Therapeutics, Inc.

NASDAQ:SLNO

52.73 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q1
Revenue 003.44600000000000000000000000734.94600.0010.2650.2840.3290.3910.4470.2420.0920.0320.02200000003
Cost of Revenue 0.4940.490.4890.5570.5980.5680.5190.5650.5630.5630.5160.5610.5650.565000000000000819.8472.6890.0420.2090.2220.3990.4280.4610.2570.0560.0220.01800000000
Gross Profit -0.494-0.492.957-0.557-0.598-0.568-0.519-0.565-0.563-0.563-0.516-0.561-0.565-0.565000000000000-84.901-2.689-0.0410.0560.061-0.07-0.037-0.014-0.0150.0360.010.00400000003
Gross Profit Ratio 000.85800000000000000000000000-0.1160-410.2110.217-0.213-0.095-0.031-0.0630.3910.3130.18200000001
Reseach & Development Expenses 12.34214.6028.6896.0435.1415.3163.813.7713.6963.9883.7344.9685.5877.1645.5664.8276.1036.6955.2724.493.7452.762.1922.0921.7141.181.0230.9820.9740.9940.9541.1311.3271.7721.2841.1931.1810.8780.6090.7170.5490.3720.360.7450.5720.703
General & Administrative Expenses 10.8898.4724.143.3183.1692.8542.4022.3322.4672.6432.5962.7672.4642.9792.2512.2562.2482.0031.6081.6151.6952.0121.3651.5581.7661.8671.6851.7072.1951.1581.891.3981.5091.9391.7091.7141.4321.2921.080.5220.7460.3120.20.2480.6040.416
Selling & Marketing Expenses -0.4940-0.48900000000000000000000000-00.00100.1140.1740.3420.5770.5380.4980.4670.5060.260.1560.0840.01200000
SG&A 10.3958.4723.6513.3183.1692.8542.4022.3322.4672.6432.5962.7672.4642.9792.2512.2562.2482.0031.6081.6151.6952.0121.3651.5581.7661.8671.6841.7072.1951.2722.0641.742.0862.4772.2072.1811.9381.5521.2370.6060.7580.3120.20.2480.6040.416
Other Expenses 1.6370.4011.0811.0210.3130.299-0.1320.1320.616000.5513.03404.340.7742.8420.5840.2890.0280.1830.2060.567-0.2280.0030.0030.0130.0040-0.6090.02-0.009-0.016-0.096-0.001-0.183-0.0650-3.69-0.31800.238-0.105-0.026-0.0260.077
Operating Expenses 22.73723.47512.3410.3828.318.176.2126.1036.1636.6316.337.7358.05110.1437.8177.0838.3518.6986.886.1055.444.7723.5573.653.483.0472.7072.6893.1692.2663.0182.8713.4134.2493.4923.2193.0542.431.8461.3231.3070.6840.560.9931.1761.119
Operating Income -23.231-21.398-12.829-10.861-8.623-8.469-5.61-6.235-6.7795.773-3.001-8.286-11.0859.156-7.957-7.857-11.193-9.282-6.752-6.105-5.623-4.978-3.535-3.878-3.413-3.475-5.199-2.689-3.21-2.21-2.956-2.941-3.45-4.263-3.507-3.183-3.044-2.426-1.846-1.323-1.307-0.684-0.56-0.993-1.1761.881
Operating Income Ratio 00-3.72300000000000000000000000-0.0070-3,210-8.34-10.417-8.939-8.824-9.537-14.517-34.598-95.125-110.27300000000.627
Total Other Income Expenses Net 1.3771.6761.533-1.674-0.3120.1130.1240.1030.054-11.4973.468-0.439-2.9781.1884.965-1.4630.9662.829-7.7666.965-4.615-2.3154.0871.315-3.764-0.213-3.4170.134-0.032-0.6780.3650.191-0.0631.0740.661-0.114.925-6.174-3.69-0.318-0.8160.238-0.105-0.026-0.0260.077
Income Before Tax -21.854-21.398-11.296-10.861-8.475-8.356-5.486-6.132-6.725-5.724-2.828-8.14-10.988-8.954-2.852-8.545-7.384-5.858-14.6250.889-10.008-7.030.393-2.309-7.214-3.241-6.131-2.551-3.239-2.887-2.592-2.75-3.513-3.189-2.845-3.2931.881-11.651-7.856-2.393-2.793-0.834-0.974-1.59-2.1571.014
Income Before Tax Ratio 00-3.27800000000000000000000000-0.0080-3,239-10.894-9.132-8.359-8.985-7.134-11.776-35.79358.781-529.59100000000.338
Income Tax Expense 01.1862.004-2.1640.165-0.005-1.7410.1591.124-1.814-3.5020.4052.937-1.189-5.4530.973-0.967-2.847.255-7.1174.4032.0681.494-0.9144.160.711-1.9621.1010.7560.06821.7-0.0090.047-1.17-4.412-0.073-4.9250.001-1.3710.4281.4860.6250.2050.5450.9291.022
Net Income -21.854-21.398-11.296-10.861-8.475-8.351-3.745-6.291-7.849-3.91-2.828-8.14-10.988-8.954-2.852-8.545-7.384-5.858-14.6250.889-10.008-7.030.263-2.736-7.637-3.755-5.025-3.786-3.966-2.887-2.613-2.75-3.513-3.189-2.845-3.2931.881-11.651-7.856-2.393-2.793-0.834-0.974-1.59-2.1571.014
Net Income Ratio 00-3.27800000000000000000000000-0.0070-3,966-10.894-9.208-8.359-8.985-7.134-11.776-35.79358.781-529.59100000000.338
EPS -0.57-0.59-0.33-0.95-0.81-0.88-0.4-0.67-0.84-0.73-0.53-1.53-2.07-1.69-0.54-1.61-2.4-1.97-5.330.45-4.72-3.320.15-1.91-5.63-2.88-3.86-5.87-6.25-8.51-7.3-13.09-16.97-16.16-14.42-24.618.75-125.45-87.04-27.73-149.51-44.64-52.15-85.11-115.4754.28
EPS Diluted -0.57-0.59-0.33-0.95-0.81-0.88-0.4-0.67-0.84-0.73-0.53-1.53-2.07-1.69-0.54-1.61-2.4-1.97-5.33-2.85-4.72-3.320.15-1.91-5.63-2.88-3.86-5.87-6.25-8.51-7.3-13.09-16.97-16.16-14.42-24.618.75-125.45-84.58-27.73-149.51-44.64-52.15-85.11-115.4754.28
EBITDA -22.737-21.398-12.34-10.861-7.509-7.871-6.813-5.481-5.057-7.024-9.306-6.804-4.583-10.842-12.782-5.62-8.829-11.0380.886-12.703-0.501-2.158-7.644-4.4750.778-2.3391.305-2.36-2.759-1.99-4.465-2.911-3.368-5.413-7.867-3.228-7.953-5.461-5.528-1.641-0.484-0.44-0.654-1.007-1.1921.97
EBITDA Ratio 00-3.581000000000000000000000000.0020-2,759-7.509-15.732-8.848-8.614-12.11-32.57-35.087-248.531-248.22700000000.657